[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566975":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":35,"responsibleParty":254,"collaborators":256,"id":259,"slug":260,"hasResults":261,"nctId":262,"briefTitle":263,"officialTitle":264,"acronym":265,"eligibilityCriteria":266,"healthyVolunteers":261,"sex":267,"minAge":268,"maxAge":25,"enrollmentInfo":269,"targetDuration":25,"studyType":272,"phases":273,"briefSummary":275,"conditions":276,"keywords":281,"overallStatus":108,"whyStopped":25,"lastUpdateSubmitDate":285,"lastUpdatePostDateStruct":286,"startDateStruct":289,"completionDateStruct":291,"leadSponsor":293,"locationsCount":294},{"fullName":5,"class":6},"i-Lumen Scientific AUS PTY LTD","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active i-Lumen AMD therapy","EXPERIMENTAL","Active transpalpebral microcurrent therapy",[13],"Device: i-Lumen AMD",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham i-Lumen AMD therapy","SHAM_COMPARATOR","Sham transpalpebral microcurrent therapy",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","i-Lumen AMD","i-Lumen AMD transpalpebral microcurrent stimulation system",[9,15],null,[27],{"name":28,"affiliation":5,"role":29},"Meredith Mundy","STUDY_DIRECTOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":25,"email":34},"CONTACT","408-440-7049","mmundy@i-lumen.com.au",[36,58,73,90,106,126,143,155,170,189,204,222,238],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Retina Consultants PC","NOT_YET_RECRUITING","Manchester","Connecticut","06042","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-72.52148,41.77593,{"lat":48,"lon":47},[51,55],{"name":52,"role":32,"phone":53,"phoneExt":25,"email":54},"Chris Research Coordinator","860-646-7704 x113","cdwy@retinact.com",{"name":56,"role":57,"phone":25,"phoneExt":25,"email":25},"Noam Rudnick, MD","PRINCIPAL_INVESTIGATOR",{"facility":59,"status":38,"city":60,"state":61,"zip":62,"country":42,"countryCode":43,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"University Retina & Macula Associates","Lemont","Illinois","60439",{"type":45,"coordinates":64},[65,66],-88.00173,41.67364,{"lat":66,"lon":65},[69],{"name":70,"role":32,"phone":71,"phoneExt":25,"email":72},"Clinical Research Manager","708-765-4110","maggieb@uretina.com",{"facility":74,"status":38,"city":75,"state":76,"zip":77,"country":42,"countryCode":43,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Texas Retina Associates","Fort Worth","Texas","76104",{"type":45,"coordinates":79},[80,81],-97.32085,32.72541,{"lat":81,"lon":80},[84,88],{"name":85,"role":32,"phone":86,"phoneExt":25,"email":87},"Lori Research Coordinator","817-334-0882 x411","lmullen@texasretina.com",{"name":89,"role":57,"phone":25,"phoneExt":25,"email":25},"Patrick Williams, MD",{"facility":91,"status":38,"city":92,"state":76,"zip":93,"country":42,"countryCode":43,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"Tyler Retina Research Insitute","Tyler","75703",{"type":45,"coordinates":95},[96,97],-95.30106,32.35126,{"lat":97,"lon":96},[100,104],{"name":101,"role":32,"phone":102,"phoneExt":25,"email":103},"Melissa Long Research Coordinator","903-597-4644","mlong@tylerretina.com",{"name":105,"role":57,"phone":25,"phoneExt":25,"email":25},"Samuel Minaker, MD",{"facility":107,"status":108,"city":109,"state":110,"zip":111,"country":112,"countryCode":113,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Sydney Eye Hospital","RECRUITING","Sydney","New South Wales","2000","Australia","AU",{"type":45,"coordinates":115},[116,117],151.20732,-33.86785,{"lat":117,"lon":116},[120,124],{"name":121,"role":32,"phone":122,"phoneExt":25,"email":123},"i-SIGHT2 MRG Coordinator","+61 2 9382 7309","i-sight2.mrg.coordinator@groups.sydney.edu.au",{"name":125,"role":57,"phone":25,"phoneExt":25,"email":25},"Samantha Fraser-Bell, BSc, MBBS, MHA, MPH, PhD",{"facility":127,"status":108,"city":128,"state":129,"zip":130,"country":112,"countryCode":113,"cosmosGeoPoint":131,"geoPoint":135,"contacts":136},"Hobart Eye Surgeons","Hobart","Tasmania","7000",{"type":45,"coordinates":132},[133,134],147.32941,-42.87936,{"lat":134,"lon":133},[137,141],{"name":138,"role":32,"phone":139,"phoneExt":25,"email":140},"Jackie Research Coordinator","+61 (03) 6210 6000","Jacqueline.Townley@eyesurgeons.com.au",{"name":142,"role":57,"phone":25,"phoneExt":25,"email":25},"Nitin Verma, MD, MBBS",{"facility":144,"status":108,"city":145,"state":146,"zip":147,"country":112,"countryCode":113,"cosmosGeoPoint":25,"geoPoint":25,"contacts":148},"Adelaide Eye & Retina Centre","Adelaide","Victoria","5000",[149,153],{"name":150,"role":32,"phone":151,"phoneExt":25,"email":152},"Kerin Research Coordinator","+61 08 8212 3022","khaywood@adelaideeye.com.au",{"name":154,"role":57,"phone":25,"phoneExt":25,"email":25},"Jagjit Jolly Gilhotra",{"facility":156,"status":108,"city":157,"state":146,"zip":25,"country":112,"countryCode":113,"cosmosGeoPoint":158,"geoPoint":162,"contacts":163},"Cerulea","East Melbourne",{"type":45,"coordinates":159},[160,161],144.9879,-37.81667,{"lat":161,"lon":160},[164,168],{"name":165,"role":32,"phone":166,"phoneExt":25,"email":167},"Regina Research Coordinator","+61 3 9959 0050","RCallegher@ceruleaclinicaltrials.org.au",{"name":169,"role":57,"phone":25,"phoneExt":25,"email":25},"Robyn Guymer",{"facility":171,"status":108,"city":172,"state":173,"zip":174,"country":175,"countryCode":176,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Auckland Eye Limited","Remuera","Auckland","1050","New Zealand","NZ",{"type":45,"coordinates":178},[179,180],174.79819,-36.88041,{"lat":180,"lon":179},[183,187],{"name":184,"role":32,"phone":185,"phoneExt":25,"email":186},"Alice Research Coordinator","64 09 529 2480","Alice@aucklandeye.co.nz",{"name":188,"role":57,"phone":25,"phoneExt":25,"email":25},"Riyaz Bhikoo",{"facility":190,"status":108,"city":191,"state":25,"zip":25,"country":175,"countryCode":176,"cosmosGeoPoint":192,"geoPoint":196,"contacts":197},"Southern Eye Specialist","Christchurch",{"type":45,"coordinates":193},[194,195],172.63333,-43.53333,{"lat":195,"lon":194},[198,202],{"name":199,"role":32,"phone":200,"phoneExt":25,"email":201},"Marie Research Coordinator","64 03 355 6397","marie@southerneye.co.nz",{"name":203,"role":57,"phone":25,"phoneExt":25,"email":25},"James Borthwick",{"facility":205,"status":108,"city":206,"state":25,"zip":207,"country":208,"countryCode":209,"cosmosGeoPoint":210,"geoPoint":214,"contacts":215},"King's College Hospital","London","SE5 9RS","United Kingdom","UK",{"type":45,"coordinates":211},[212,213],-0.12574,51.50853,{"lat":213,"lon":212},[216,220],{"name":217,"role":32,"phone":218,"phoneExt":25,"email":219},"Nikki Research Coordinator","+44 203 299 7791","noimottimson@nhs.net",{"name":221,"role":57,"phone":25,"phoneExt":25,"email":25},"Timothy Jackson, PhD, FRCOphth",{"facility":223,"status":108,"city":224,"state":25,"zip":225,"country":208,"countryCode":209,"cosmosGeoPoint":226,"geoPoint":230,"contacts":231},"London North West University Healthcare","Middlesex","HA1 3UJ",{"type":45,"coordinates":227},[228,229],-0.26856,51.53174,{"lat":229,"lon":228},[232,236],{"name":233,"role":32,"phone":234,"phoneExt":25,"email":235},"Sandali Research Coordinator","+44 (0) 208 453 2077","snammuniarachchge@nhs.net",{"name":237,"role":57,"phone":25,"phoneExt":25,"email":25},"Christiana Dinah, BSc, MB BS, MRes, FRCOphth",{"facility":239,"status":108,"city":240,"state":25,"zip":241,"country":208,"countryCode":209,"cosmosGeoPoint":242,"geoPoint":246,"contacts":247},"Sunderland Eye Infirmary","Sunderland","SR2 9HP",{"type":45,"coordinates":243},[244,245],-1.38222,54.90465,{"lat":245,"lon":244},[248,252],{"name":249,"role":32,"phone":250,"phoneExt":25,"email":251},"SEI Research Nurses Research Coordinator","0191 5699074","stsft.seiresearchnurses@nhs.net",{"name":253,"role":57,"phone":25,"phoneExt":25,"email":25},"Ajay Kotagiri",{"type":255,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[257],{"name":258,"class":6},"i-Lumen Scientific, Inc.","100566975","microcurrent-stimulation-therapy-for-intermediate-to-advanced-nonexudative-age-related-macular-degeneration-100566975",false,"NCT06662162","Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration","Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration (i-SIGHT2): a Multicentre, Randomised, Sham-controlled, Double-masked, Clinical Device Trial.","i-SIGHT2","Key Inclusion Criteria:\n\n* Presence of at least one large druse \\>125 microns in diameter due to AMD.\n* BCVA letter score of 35 to 70 letters (inclusive) (Snellen equivalent 6\u002F12 to 6\u002F60 \\[20\u002F40 to 20\u002F200\\])\n\nKey Exclusion Criteria:\n\n* Any implanted electrical device(s) including deep brain stimulator, hearing or visual implants (i.e., cochlear implant, auditory brainstem implant, retinal prostheses), and\u002For cardiac defibrillator\u002Fpacemaker.\n* Implanted metallic device within 20 cm of the Treatment electrode (study eye(s)) and\u002For the grounding electrode (base of the hairline on the back of the neck).\n* Uncontrolled diabetes, defined as glycated haemoglobin (HbA1c) \\>10% (13.3 mmol\u002FL).\n* Current tobacco or tobacco-related product use or history within the past 5 years of heavy smoking (defined as, on average, more than half a pack of cigarettes per day).\n* Known severe allergy to fluorescein dye.\n* Medical diagnosis of severe dry eye defined as requiring either artificial tears more than six (6) times a day or prescription drops (i.e., Restasis, Xiidra, or Cequa).\n* History of seizure disorders, chronic migraines and\u002For cluster headaches.\n* History and\u002For evidence of diabetic retinopathy in either eye as assessed by CF, fundus fluorescein angiography (FA), and OCT, to be confirmed by the Central Reading Centre.\n* Other conditions which pre-dispose to chorioretinal atrophy such as inherited retinal dystrophy (i.e., Stargardt's disease, Best's disease, pattern dystrophy, central areolar choroidal dystrophy, etc.).\n* History and\u002For evidence of exudative AMD in the study eye as assessed by CF, FA (or OCT-A ), and OCT, to be confirmed by Central Reading Centre.\n* GA involving the foveal centre, as assessed by the Central Reading Centre using AF and OCT.\n* History of intravitreal injections for GA (e.g., Syfovre or Izervay).\n* Treatment with photobiomodulation (PBM) therapy or short pulse laser within 12 months prior to screening.\n* Glaucoma requiring ≥3 medications and\u002For drops per day, or history of trabeculectomy.\n* History of any kind of intraocular surgery, excluding cataract surgery performed ≥3 months from Screening.\n* History of yttrium aluminium garnet (YAG) laser posterior capsulotomy \\\u003C1 month from Screening.\n* Visually significant cataracts and\u002For visually significant posterior capsular opacification.\n* History of amblyopia.","ALL","60 Years",{"count":270,"type":271},100,"ESTIMATED","INTERVENTIONAL",[274],"NA","The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD.\n\nParticipants will:\n\n* Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months.\n* Participants will return monthly through Month 14 (3 months post-last treatment) for evaluation and monitoring.",[277,278,279,280],"Age-Related Macular Degeneration","Age-related Macular Degeneration (ARMD)","Intermediate AMD","Geographic Atrophy Secondary to Age-related Macular Degeneration",[282,279,283,284],"AMD","Dry AMD","Geographic Atrophy","2026-05-01",{"date":287,"type":288},"2026-05-04","ACTUAL",{"date":290,"type":288},"2025-05-07",{"date":292,"type":271},"2029-12-31",{"name":5,"class":6},13]